Patent · US Active

Antibody producing non-human mammals

US9951124B2 · kind B2 · utility

7Cited by
32References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 25, 2013
Grant dateApr 24, 2018
Priority date
Expiry dateJul 19, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/56966
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Described are transgenic, non-human animals comprising a nucleic acid encoding an immunoglobulin light chain, whereby the immunoglobulin light chain is human, human-like, or humanized. The nucleic acid is provided with a means that renders it resistant to DNA rearrangements and/or somatic hypermutations. In one embodiment, the nucleic acid comprises an expression cassette for the expression of a desired molecule in cells during a certain stage of development in cells developing into mature B cells. Further provided is methods for producing an immunoglobulin from the transgenic, non-human animal.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.